Targeting EZH2 in SMARCB1-deficient sarcomas: Advances and opportunities to potentiate the efficacy of EZH2 inhibitors
Cinzia Lanzi, Noemi Arrighetti, Sandro Pasquali, Giuliana Cassinelli
Topics & Concepts
EZH2PRC2ChromatinCancer researchEpigeneticsEpithelioid sarcomaChromatin remodelingMedicineBiologySarcomaPathologyGeneticsDNAGeneChromatin Remodeling and CancerCancer Mechanisms and TherapyProtein Degradation and Inhibitors